There are 2949 resources available
957P - Ameloblastoma of the head and neck (HNAMB): A comprehensive profiling (CGP) study
Presenter: Prasanth Reddy
Session: E-Poster Display
Resources:
Abstract
958P - Circulating tumour DNA as a biomarker in head and neck squamous cell carcinoma
Presenter: Ning Jia
Session: E-Poster Display
Resources:
Abstract
959P - Analysis of concurrent chemo-radiation using weekly cisplatin in locally advanced SCCHN: Identification of prognostic factors
Presenter: Atul Sharma
Session: E-Poster Display
Resources:
Abstract
960P - A real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: A prospective observation study (JROSG12-2)
Presenter: Tomoya Yokota
Session: E-Poster Display
Resources:
Abstract
961P - Genomic and transcriptomic profiling in head and neck tumours to identify treatment options: The WINTHER trial experience
Presenter: Irene Braña
Session: E-Poster Display
Resources:
Abstract
962P - Immunotherapeutic implications of mucin 1/16 expression in head and neck squamous cell carcinoma (HNSCC)
Presenter: Theodoros Rampias
Session: E-Poster Display
Resources:
Abstract
963P - Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma
Presenter: Luigi Lorini
Session: E-Poster Display
Resources:
Abstract
964P - Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways
Presenter: Chiara Romani
Session: E-Poster Display
Resources:
Abstract
965P - Role of STAT3 (signal transducer and activator of transcription 3) activation and its regulation by PTPRT (protein receptor tyrosine phosphatase type T) and response to paclitaxel and cetuximab in patients (P) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
Presenter: Beatriz Cirauqui Cirauqui
Session: E-Poster Display
Resources:
Abstract
966P - Activation of the Wnt/PCP signaling pathway is an adverse prognostic predictor in patients with low grade glioma (LGG)
Presenter: Lan Su
Session: E-Poster Display
Resources:
Abstract